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Abstract
Background: This paper discusses the way in which women’s health concerns were addressed in Mexico as part of
a health system reform.
Discussion: The first part sets the context by examining the growing complexity that characterizes the global
health field, where women’s needs occupy center stage. Part two briefly describes a critical conceptual evolution,
i.e. from maternal to reproductive to women’s health. In the third and last section, the novel “women and health”
(W&H) approach and its translation into policies and programs in the context of a structural health reform in
Mexico is discussed. W&H simultaneously focuses on women’s health needs and women’s critical roles as both
formal and informal providers of health care, and the links between these two dimensions.
Summary: The most important message of this paper is that broad changes in health systems offer the
opportunity to address women’s health needs through innovative approaches focused on promoting gender
equality and empowering women as drivers of change.
Keywords: Women and health, Mexican health reform, Fair Start in Life
Background
Despite important global progress, women’s health and,
in particular, sexual and reproductive health, are still
very much a part of the unfinished agenda. Indeed, girls
and women face health challenges that have not yet been
fully addressed. In fact, millions of women lack access to
basic life-saving services and hundreds of thousands of
women suffer death or disability every year from pre-
ventable diseases and complications of pregnancy. Every
two minutes a woman unnecessarily dies of preventable
pregnancy-related complications, [1] leaving behind
impoverished orphans, struggling families, and deva-
stated communities. Around the world, 200 million ado-
lescent girls and women do not have access to safe and
effective contraception —the fundamental tool for con-
trolling their reproductive lives. Females still struggle
with unwanted pregnancy, maternal morbidity and mor-
tality, unsafe abortion, and reproductive cancers.
Along with the biological risks, women and girls are
affected by gender and other social inequalities, which are
the underlying conditions for pervasive problems such as
gender-based violence and the “feminization” of the HIV/
AIDS epidemic. At later stages of life, women receive
poorer and later care for problems they share with men,
such as cardiovascular disease and lung cancer.
Novel visions and strategies are required to tackle girls’
and women’s unmet health needs and to challenge gen-
der and other social inequalities. Efforts to address each
of these issues must recognize that women are, simul-
taneously, consumers and producers of health care [2].
Mothers, sisters, and grandmothers are the primary
caretakers in their households, and female community
workers and midwives serve people who otherwise lack
access to health services because they live in remote
areas or cannot afford care. Women often are the most
active members of community health committees and
other forms of organization of civil society. They also
represent a majority in the health professions, make key
contributions to the health sciences and academia, and
strategically set priorities and allocate health care fund-
ing as decision makers around the globe. Gender-related
barriers and lack of enabling policies to help balance life
and work prevent women from achieving their full po-
tential in the health workforce.
* Correspondence: ocogomez@yahoo.com
2Center for Health Systems Research, National Institute of Public Health,
Avenida Universidad 655, C.P. 62100 Cuernavaca, Morelos, Mexico
Full list of author information is available at the end of the article
© 2012 Frenk et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
Frenk et al. BMC Women's Health 2012, 12:42
http://www.biomedcentral.com/1472-6874/12/42The purposes of this paper are to present a concrete
experience that illustrates this comprehensive approach
and to discuss its translation into policies and programs.
We analyze this experience in the context of a structural
health reform implemented in Mexico between 2000
and 2006 and the growing complexity that characterizes
the global health field, where women’s needs occupy
center stage. The framework for our discussion is a crit-
ical conceptual evolution that has taken place in the last
decades, i.e. from maternal to reproductive to women’s
health throughout the life cycle. The most important
message we want to convey through this paper is that
broad changes in health systems offer the opportunity to
address women’s health needs through innovative
approaches focused on promoting gender equality and
empowering women as drivers of change.
Discussion
Challenges of global health
Today we are all keenly aware that in health matters the
world has become a neighborhood: “a place you are
already in when you walk out your door [3]”. This
awareness comes at a time of unprecedented change: we
are in the midst of a major health transition unlike any-
thing the world has seen before.
To begin with, during the 20
th century the world as a
whole experienced a larger gain in life expectancy than
in all the previously accumulated history of humankind.
Average life expectancy in the world increased from 30
years in 1900 to 66.6 years in 2009.
We have also witnessed a shift in the dominant patterns
of disease. The relative importance of different causes of
death has changed from acute infections in children to
chronic non-communicable disorders in adults.
The whole meaning of disease has also been trans-
formed. Previously, the experience of disease was
marked by a succession of acute episodes from which
one either recovered or died. Now people spend sub-
stantial parts of their lives in less than perfect health,
coping with a chronic condition, often stigmatized.
The ongoing health revolution has undoubtedly pro-
duced enormous benefits, but it has also opened new
challenges. Equity is the most daunting of all. Progress
on the health transition has not been shared equally by
all nations of the world. Whereas rich countries experi-
enced a substitution of old for new patterns of disease,
the developing world is simultaneously facing a triple
burden of ill health: first, the unfinished agenda of infec-
tions, under-nutrition, and reproductive health pro-
blems; second, the emerging challenges represented by
non-communicable diseases, mental disorders, and the
growing scourge of injury and violence; and third, the
health risks associated with globalization, including the
threat of pandemics like AIDS and influenza, the trade in
harmful products like tobacco and other drugs, the health
consequences of climate change, and the dissemination of
harmful lifestyles leading to the epidemic of obesity.
From maternal to reproductive to Women’s health
In the context of this protracted health transition, the
concepts that reflect the priority of different aspects of
women’s health have themselves been evolving. Until late
last century, the concept that prevailed was that of ‘ma-
ternal and child health’ (MCH), which considered the
well-being of women as a vehicle to improve children´s
health, instead of a legitimate end in itself. In the mid-
1980s, this insufficient attention to women was strongly
confronted by Rosenfield and Maine in their classical
article on the invisibility of the maternal health compo-
nent in the maternal and child health programs [4]. A
few years later, UN bodies and non-governmental orga-
nizations launched the Safe Motherhood Initiative
(SMI), which represented the first global effort to ad-
dress maternal health. Focused on health during preg-
nancy, delivery and the post-partum, the SMI meant a
gradual shift from an exclusive concern for survival to a
broader interest in the prevention of disability and the
positive promotion of well-being [5].
It is important to mention that a work written by the
Boston Women’s Health Book Collective in the early
1970s, Our Bodies, Ourselves, had disseminated a broader
approach to women’s health that was well ahead of its
time. This book contained information on many issues
related to women’s health and sexuality, including birth
control, childbirth, sexual health, sexual orientation, and
gender identity [6].
While maternal health was slowly gaining visibility, in
the mid 1990’s the international health community,
prompted by a solid grassroots movement, moved be-
yond a demographic/population control approach and
embraced the comprehensive concept of sexual and re-
productive health and rights (SRHR) that includes ma-
ternal health, but transcends it [7]. In 1994 and 1995, at
the International Conference on Population and Develop-
ment in Cairo and the Fourth World Conference for
Women in Beijing, respectively, the vast majority of
countries officially adopted the new SRHR paradigm [8,9].
Over the following years, attention on maternal health
gradually increased and safe and effective interventions
that allow preventing maternal deaths when accessible to
women with obstetric complications were developed [10].
In spite of this progress, maternal health continues to be a
major priority in the global health agenda: approximately
300 thousand women every year are still losing their lives
in the process of giving life [1,11]. The fact that 99% of
these deaths happen in developing countries makes mater-
nal mortality ratio the most inequitably distributed health
indicator in the world [12]. The inacceptable persistence
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prompted the global community to dedicate one of the
eight Millennium Development Goals (MDG number 5)
to its reduction, committing to bring the 1990 levels down
by two-thirds in 2015 [13].
In more recent years, to a great extent because of a rising
awareness of the inextricable links between women’sh e a l t h
conditions along the life cycle and the increasing preva-
lence of non-communicable diseases among women in
developing countries, the expanded concept of ‘women’s
health’ gained currency in the global arena. “Women’s
health” has maternal and reproductive health at its core,
but goes beyond that to include emerging challenges that
are both practically exclusive to women—like cervical and
breast cancer—or particularly common among them, such
as depression, the increasing consumption of tobacco, and
obesity [14]. This new emphasis adds an additional layer
of complexity to the health challenges women face. In the
last few years, other broader approaches to women’s
health have been promoted, including the economic
dimension of maternal health and “women-centered de-
velopment” [15,16].
In Mexico, a comprehensive approach to women’s
health was developed around the concept of ‘women
and health’ and implemented between 2000 and 2006.
This effort was part of a larger initiative to reform the
health system [17-23]. The main features of the reform
are briefly described below as the larger context for the
implementation of the broad and ambitious women and
health agenda.
Addressing Women’s concerns in the context of the
Mexican health reform
The calculation of national health accounts in Mexico in
the 1990s revealed that more than 50% of total health
expenditure was out-of-pocket, due the fact that more
than half of the population (around 50 million people)
lacked health insurance [24]. This type of expenditures
exposed households to ruinous situations. In fact, further
analyses demonstrated that close to 4 million households
were paying catastrophic and/or impoverishing sums to
meet the health needs of their family members [25].
These and other analyses generated the evidence that
supported a legislative reform that established a system
of social protection in health, which was approved by a
large majority of the Mexican Congress in 2003. One of
the main objectives of this reform was to increase public
funding by a full percentage point of the GDP over
seven years in order to provide universal health insur-
ance. The vehicle for achieving this aim is a public
scheme called Seguro Popular (Popular Health Insurance
in English), which guarantees regular access to a package
of more than 250 essential interventions which include
all services offered in ambulatory units and general
hospitals of the Ministry of Health (MoH), and a pack-
age of 57 costly interventions which includes treatment
for all types of cancer in children, cervical and breast
cancer, and HIV/AIDS [26]. This insurance has elicited
an enthusiastic response from the population, so that by
December of 2011 more than 51.8 million people were
enrolled in it and the target of universal coverage has
been reached in 2012 [27,28].
In the context of a structural reform addressing the
cross-cutting challenge of financing universal access to
high-quality services, it was necessary to have a clear
sense of priorities. This was seen as an imperative not
only in terms of resource allocation, but also to garner
public support by relating the abstract financial and
managerial notions to concrete deliverables. Every re-
form must have a limited number of “flagship initiatives”
to focus attention on its concrete benefits. From the out-
set, it was decided that a comprehensive approach to ad-
dress women’s health’ would be one of them.
The first and most pressing priority in Mexico was to
reduce maternal deaths. Having already achieved over
95% coverage with one of the most complete immuni-
zation schedules in the world [29], the next frontier for
equity was to close the social gaps in maternal mortality.
Indeed, at the beginning of this decade, the progress
reports produced by the United Nations showed that
Mexico was one of the very few developing countries that
were on route to meet the health-related MDGs except
for one indicator: maternal mortality. In 1990 the mater-
nal mortality ratio for Mexico was 90.4 and in order to
meet MDG 5 it should decline to 22.6 in 2015, a goal that
looks unreachable, given the present level of this indicator
(36.1 in 2010) [30]. Like for the rest of the world, this was
the indicator exhibiting the highest degree of inequality
across social groups and regions of the country. Even
though maternal deaths on average had decreased consist-
ently in the previous decade, major efforts were still
needed in the poorest areas of the southern states of
Mexico, where geographic, organizational, financial, and
cultural barriers limited women’s access to maternal
health care [31]. The differences among states were huge.
The northern state of Nuevo León had a maternal mortal-
ity ratio of 16 in 2004 while the southern state of Chiapas
showed a ratio of 103 [32].
In rural areas of Mexico maternal deaths were mostly
associated to acute obstetric hemorrhage, which demanded
improvements in timely access to skilled delivery care.
Hemorrhage was responsible for 25% of maternal deaths
in 2004 [29]. In urban settings most maternal deaths were
due to eclampsia, which concentrated 30% of maternal
deaths nationally that same year. Indirect obstetric ail-
ments were the main cause of maternal deaths.
To address maternal morbidity and mortality and
closely related perinatal health challenges, the special
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Vida” in Spanish) was launched in 2001. The main pur-
poses of the initiative were to address the health pro-
blems of newborns and children under 5 and the
reduction of maternal mortality. The name of program
was meant to underscore the fundamental value of
equality of opportunity.
The maternal component of the program included spe-
cific budget allocations to strengthen health-care networks
and the supply of drugs and other inputs, including safe
blood. The availability of skilled human resources was also
improved through the reintroduction of obstetric nurses,
a figure that began to disappear in the last quarter of the
past century as pregnancy and delivery became increas-
ingly medicalized [33]. The training of traditional birth
attendants by NGOs and ad hoc groups organized by local
health authorities was also strengthened to respond to the
demands of women in indigenous communities. Measures
were taken to expand coverage of antenatal care and insti-
tutional deliveries, with emphasis on timely diagnosis and
treatment of obstetric emergencies. Finally, efforts were
developed to monitor maternal deaths, including the re-
view of all deaths of women of reproductive age through
verbal autopsies [34].
As a result of these measures, effective coverage of
antenatal care and skilled attendance at birth increased
from less than 90% in 2000 to 93% in 2006, with small
variations among states. Most importantly, there was a
significant acceleration in the rate of decline of maternal
mortality. Between 1990 and 2000, the indicator had
dropped an average of 1.6% per year [35]. But the aver-
age rate of decline more than doubled between 2000 and
2006 to reach 2.7% per year, reflecting a drop in the
number of maternal deaths from 72 to 58 per 100,000
live births, one of the lowest figures in Latin America
[36,37]. It is important to stress that there was also a re-
duction of the gap between the rich states in the north
and the poor ones in the south.
In the field of sexual and reproductive health, the
MOH explicitly promoted the rights of women and car-
ried out a number of innovative initiatives. One of the
most relevant and by far the most controversial change
was the revision of the national family planning policy
through the introduction of three new contraceptive
methods in the essential drug list: the sub-dermic implant,
the female condom, and emergency contraception. The ap-
proval of the latter ignited an intense public debate, which
provided useful lessons for Mexico and other countries
dealing with similar challenges.
Emergency contraception was included in the essential
drug list in July of 2005, after a lengthy and public discus-
sion on its mechanisms of action, and associated risks and
adverse effects, in which hundreds of organizations parti-
cipated. The approval faced the strong opposition of the
leaders of the Catholic Church, several conservative
groups, and distinguished members of the party in power,
all of whom argued, against nationally and internationally
generated scientific evidence, that emergency contracep-
tion induces abortion [38]. Women’s rights advocates
argued that access to emergency contraception was a top
priority in a country with a high prevalence of unwanted
pregnancies, an important proportion of which results
from acts of sexual violence. Technical and scientific en-
tities contributed to the debate by providing the scientific
evidence about emergency contraception’s mechanisms of
action and assessed public opinion, which was strongly in
favor of the inclusion of this additional tool in the family
planning guidelines and public services.
A tt h ep e a ko ft h ec o n t r o v e r s y ,t h eo f f i c eo ft h eP r e s i d e n t
of Mexico supported the inclusion of emergency contra-
ception into the essential drug list stressing that it was the
recommendation that resulted from a participatory and
transparent process based on the analysis of scientific
evidence. Such a strong endorsement was the positive
culmination to a debate that in other Latin American
countries has produced major political damage [39].
According to a review of opinion surveys, this was
probably one of the most popular public policy measures
adopted by that particular administration. In a predom-
inantly Catholic nation, this decision was backed by the
majority of women even within the most religious seg-
ments of the population. A survey implemented in 2004
to assess public opinion on emergency contraception in
Mexico City showed an approval rate of 68.4% [40].
Three basic lessons can be drawn from the experience
around the introduction of emergency contraception in
the list of essential drugs of public institutions in Mexico:
first, that scientific evidence can provide major support
for controversial policy decisions; second, that it is impor-
tant to take advantage of political opportunities and work
collaboratively with strategic allies, such as civil society
organizations; and third, that given the wave of demo-
cratization that is spreading in developing countries, we
should not underestimate people’s aspiration for alterna-
tives. In this particular case, Mexicans clearly rejected the
interference of religious institutions in their private lives,
especially in issues related to sexuality.
At the same time, the Government of Mexico adopted a
gender and life-course perspective for its efforts to improve
women’s health, identifying two critical priorities: gender-
based violence and cancer. In 2003 the MOH implemented
the first National Survey on Violence against Women,
which showed that the prevalence of intimate partner
violence among users of health services was 21.6%, i.e. one
out of every five women had suffered from intimate part-
ner violence in the 12 months prior to the survey [41].
Based on these findings and those of other studies,
in 2006 the Mexican Congress passed a new law (Ley
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Violencia, in English, General Law Guaranteeing Access
to All Women to a Life Free of Violence) that punishes
psychological, physical, and patrimonial violence against
women, and mandates the immediate arrest of the pre-
sumptive aggressor and the protection of the victim [42].
Women's organizations welcomed the law's passage,
recognized it as an important step forward, and commit-
ted themselves to support its enforcement.
Cancer among women in low- and middle-income
countries is another challenge that deserves more atten-
tion. There is evidence that shows that it has been a
leading cause of death and disability worldwide for
already many years [43]. But the distribution of cancer is
changing and it is now increasingly affecting developing
regions: 55% of the new cases of cancer currently occur
in poorer nations and this figure could reach 60% by
2020 and 70% by 2050 [44,45].
The health transition described above encompasses
the fundamental shift driving the rise of cancer in the
developing world. Its protracted and complex nature is
reflected in the coexistence of cervical and breast cancer
[46]. Cervical cancer was dramatically reduced in de-
veloped countries even before its infectious nature was
discovered and an effective vaccine was developed; the-
refore, it has been traditionally categorized as part of the
“unfinished women’s health agenda”, along with infec-
tious diseases, malnutrition and reproductive health pro-
blems. In contrast, breast cancer is an exemplar of the
emerging challenges increasingly affecting developing
countries. Cervical cancer, which has become a rare dis-
ease in rich nations, results in more than 200,000 deaths
annually in developing countries. Contrary to common
perception, breast tumors are now the number one
cause of cancer-related deaths in women in all but the
poorest nations of the world. Developing countries ac-
count for 46% of the one million new cases of breast
cancer diagnosed each year worldwide and for 55% of
the resulting deaths [47].
In Mexico mortality figures for cervical cancer have
decreased consistently over the past two and a half dec-
ades due to increasing coverage of its early detection
and treatment [48,49]. However, it still produces more
than 4,000 deaths a year. Breast cancer mortality has
doubled in the last 20 years, and it is now the second
cause of death among women 30 to 54 years old [50].
Meeting these challenges required a two-pronged
strategy involving both improved early detection and
treatment. In terms of the former, the effective coverage
of Pap smears increased from 36% to 41% between 2000
and 2006, while the coverage of mammography in
women aged 40 to 69 years grew from 12% to 21% dur-
ing the same period [17]. As part of the new insurance
scheme created by the recent reform, a separate fund
was established to finance the treatment of a package of
catastrophic diseases, including cervical and breast can-
cer, the coverage of which is now universal. Neverthe-
less, closing the gaps in access to prevention and
treatment among states remains a challenge.
While these public health efforts were put in place,
cultural factors were also addressed. By and large, in the
developed world cancer has been increasingly recognized
as a disease that can be detected in its early stages and
successfully treated. In contrast, in many developing
countries, cancer continues to be hindered by the trap-
pings of prejudice and stigma. Concerned about the pos-
sibility of being abandoned by their spouses when
discovered ill, many women opt for not using available
preventative services or, when a problem is detected, not
to receive the proper treatment, mastectomy in particu-
lar [51,52]. For this reason, in Mexico the fight against
cancer is being visualized also as a struggle against the
social scourge of ignorance, stigma, discrimination,
machismo, and the dehumanizing attempt to reduce
women to a part of their bodies [53]. This topic has
gained increasing visibility in the events commemorating
the International Breast Cancer Day and has been
openly addressed by the highest health authorities of the
country and the President of Mexico himself [54].
Finally, the women and health aspect of the Mexican
reform also embraced gender as a central issue in the
health system. In 2003, the MOH established the Na-
tional Center for Gender Equity and Reproductive
Health [55]. This entity has the authority to suggest na-
tional policies related to sexual and reproductive health
and monitor and evaluate these policies as well as the
quality of public maternal and reproductive health ser-
vices. It has also promoted the adoption of a cross-
cutting gender perspective that has translated into
gender-sensitive budgets, health information disaggre-
gated by sex, and surveillance of gender biases in access
to health services and quality of care. The Center has
also started to address the role of women as informal
providers of care for family members with chronic dis-
eases; as traditional practitioners in the health teams
serving indigenous communities; and as a growing com-
ponent of the formal health workforce.
Summary
The most important women and health challenges are
far from over. There are still major threats that need to
be addressed urgently. Salient among them are the fur-
ther acceleration of the decline of maternal mortality to
achieve MDG 5 and the attention to neglected emerging
problems such as breast cancer and depression. Not-
withstanding the importance of these problems, we
should also recognize that several conceptual and empir-
ical improvements in the field of women’s health have
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and local levels. Salient among them are the global de-
cline of maternal mortality figures, the innovative
approaches to women’s health, and the successful imple-
mentation of comprehensive policies to address the
comprehensive women and health agenda at the national
level, as exemplified by the Mexican health reform ex-
perience. Future initiatives in this field should take ad-
vantage of this progress and build on it.
The Mexican experience shows that broad reform
efforts can be used to design and implement specific
initiatives addressing priority needs. In this particular
case, these were interventions to improve the reproduct-
ive and sexual rights of girls and women.
This reform experience, due to its novel nature, also
offered the opportunity to move beyond traditional
approaches to women’s health to build a comprehensive
agenda, which also includes neglected and emerging
challenges such as gender-based violence, breast cancer,
and the introduction of the gender perspective in the de-
sign, implementation, and evaluation of health policies.
Finally, we should stress that the successful implemen-
tation of the women and health approach in Mexico
resulted from the establishment of creative alliances be-
tween the government and various important actors of
the women´s health field, including researchers, women’s
groups, other NGOs and the media.
The women and health approach represents an essential
contribution to the advancement of the unfinished women’s
health agenda both from a human rights and a develop-
ment perspective, at the national and global levels.
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